πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11564949

Ameliorating nervous systems disorders

The Regents of the University of California Β· Granted Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11566253

Targeted gene demethylation in plants

The Regents of the University of California Β· Granted Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11560561

Modular polypeptide libraries and methods of making and using same

The Regents of the University of California Β· Granted Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11559585

Conjugates of active pharmaceutical ingredients

The Regents of the University of California Β· Granted Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11560356

Compounds and compositions for the treatment of cancer

The Regents of the University of California Β· Granted Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11555057

Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor

The Regents of the University of California Β· Granted Tue Jan 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11555055

Peptide inhibitors of insulin-degrading enzyme

The Regents of the University of California Β· Granted Tue Jan 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11554180

Adeno-associated virus virions with variant capsid and methods of use thereof

The Regents of the University of California Β· Granted Tue Jan 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11549127

Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod

The Regents of the University of California Β· Granted Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11547663

Unit aerosol doses for anticoagulation

The Regents of the University of California Β· Granted Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11547674

Protein-polymer hybrid biomaterials

The Regents of the University of California Β· Granted Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11548953

Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment c

The Regents of the University of California Β· Granted Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11547664

Compositions and methods for treating eosinophilic disorders

The Regents of the University of California Β· Granted Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11541044

K-Ras modulators

The Regents of the University of California Β· Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11541125

Noncrushable pill formulations

The Regents of the University of California Β· Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11536727

Therapeutic antibodies against ROR-1 protein and methods for use of same

The Regents of the University of California Β· Granted Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11530421

Self-inactivating endonuclease-encoding nucleic acids and methods of using the same

The Regents of the University of California Β· Granted Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11530240

Catheter injectable cyclic peptide pro-gelators for myocardial tissue engineering

The Regents of the University of California Β· Granted Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11530259

Therapies and methods to treat TLR2-mediated diseases and disorders

The Regents of the University of California Β· Granted Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11530398

CRISPR-Cas effector polypeptides and methods of use thereof

The Regents of the University of California Β· Granted Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11524948

Prodrugs of alpha-ketoglutarate, alpha-ketobutyrate, alpha-ketoisovalerate, and alpha-keto

The Regents of the University of California Β· Granted Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11524053

Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents

The Regents of the University of California Β· Granted Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11518818

Therapeutic anti-IgE antibodies and methods and compositions thereof

The Regents of the University of California Β· Granted Tue Dec 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11510929

Mitigation of epileptic seizures by combination therapy using benzodiazepines and neuroste

The Regents of the University of California Β· Granted Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted